• Letter
    • R
  • Jeremy  Rautenbach

    Jeremy Rautenbach

    Global Product Manager, Pall Life Sciences
  • Liz Richardson

    Liz Richardson

    Director, Health Care Products Project, Pew Charitable Trusts
  • Kyle Richardson

    Kyle Richardson

    Board Member, Co-Director of Healthcare Initiatives, NFL Alumni Association
  • Camillo Ricordi

    Camillo Ricordi

    Professor and Director, Diabetes Research Institute and Cell Transplant Center, University of Miami Miller School of Medicine
  • Marion Riggs

    Marion Riggs

    Post-Doctoral Research Fellow, Massachusetts General Hospital
  • Patrick Rivers

    Patrick Rivers

    Director of Research, Aquilo Capital
  • Isabelle Riviere

    Isabelle Riviere

    Director, Michael G. Harris Cell Therapy & Cell Engineering Facility, Memorial Sloan Kettering Cancer Center
  • Paolo Rizzardi

    Paolo Rizzardi

    CEO, Altheia Science
  • David Rodriguez

    David Rodriguez

    Director of Business Development, FreeMind Group
  • Sue  Rogers

    Sue Rogers

    Vice President Global Distribution, Patient Access & Support, Orchard Therapeutics
  • Lloyd Rose

    Lloyd Rose

    Program Manager, BioFabUSA
  • Jon Rowley

    Jon Rowley

    Founder & Chief Product Officer, RoosterBio Inc
  • Beth Roxland

    Beth Roxland

    Senior Advisor on Law, Health Policy and Ethics, Roxland Consultants Ltd
  • Krishendu Roy

    Krishendu Roy

    Professor, Robert A. Milton Endowed Chair, Director, Center for ImmunoEngineering, Georgia Tech
  • Peter Rubin

    Peter Rubin

    Endowed Professor & Chair of Plastic Surgery, Director UPMC Wound Healing Services, Professor of Bioengineering, University of Pittsburgh Medical Center
  • Morrie Ruffin

    Morrie Ruffin

    Executive Director, ARM Foundation for Cell and Gene Medicine
  • William Rust, PhD.

    William Rust, PhD.

    CEO & Co-Founder, Seraxis